These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8930547)

  • 81. Local- and systemic-mediated suppression of contact hypersensitivity in mice by several structurally unrelated classes of tumor promoters.
    Kodari E; Pavone A; Reiners JJ
    Carcinogenesis; 1991 Oct; 12(10):1933-7. PubMed ID: 1934273
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chemical and immunological properties of carcinogen-protein conjugates.
    CREECH HJ
    Cancer Res; 1952 Aug; 12(8):557-64. PubMed ID: 14945045
    [No Abstract]   [Full Text] [Related]  

  • 83. The amino-acid sequence in the phenylalanyl chain of insulin. 2. The investigation of peptides from enzymic hydrolysates.
    SANGER F; TUPPY H
    Biochem J; 1951 Sep; 49(4):481-90. PubMed ID: 14886311
    [No Abstract]   [Full Text] [Related]  

  • 84. NINETEENTH CENTURY FOUNDATIONS OF CANCER RESEARCH ADVANCES IN TUMOR PATHOLOGY, NOMENCLATURE, AND THEORIES OF ONCOGENESIS.
    TRIOLO VA
    Cancer Res; 1965 Feb; 25():75-106. PubMed ID: 14264062
    [No Abstract]   [Full Text] [Related]  

  • 85. Contact reactivity to carcinogenic polycyclic hydrocarbons.
    OLD LJ; BENACERRAF B; CARSWELL E
    Nature; 1963 Jun; 198():1215-6. PubMed ID: 13939925
    [No Abstract]   [Full Text] [Related]  

  • 86. The effect of cortisone on chemical carcinogenesis in the mouse skin.
    GHADIALLY FN; GREEN HN
    Br J Cancer; 1954 Jun; 8(2):291-5. PubMed ID: 13190095
    [No Abstract]   [Full Text] [Related]  

  • 87. Epidermal cytokinetics, DNA adducts, and dermal inflammation in the mouse skin in response to repeated benzo[a]pyrene exposures.
    Albert RE; Miller ML; Cody TE; Talaska G; Underwood P; Andringa A
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):67-74. PubMed ID: 8560481
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mechanistic relationship among mutagenicity, skin sensitization, and skin carcinogenicity.
    Ashby J; Hilton J; Dearman RJ; Callander RD; Kimber I
    Environ Health Perspect; 1993 Apr; 101(1):62-7. PubMed ID: 8513766
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters.
    Wei H; Frenkel K
    Carcinogenesis; 1993 Jun; 14(6):1195-201. PubMed ID: 8508507
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
    Spalding JW; Momma J; Elwell MR; Tennant RW
    Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An overview of glucocorticoid anti-inflammatory actions.
    Schleimer RP
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S3-7; discussion S43-4. PubMed ID: 8313932
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prediction of rodent carcinogenicity for 44 chemicals: results.
    Ashby J; Tennant RW
    Mutagenesis; 1994 Jan; 9(1):7-15. PubMed ID: 8208133
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Carcinogen risk assessment in the U.S. Environmental Protection Agency.
    Albert RE
    Crit Rev Toxicol; 1994; 24(1):75-85. PubMed ID: 8172652
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ultraviolet B-induced local immunosuppression of contact hypersensitivity is modulated by ultraviolet irradiation and hapten application.
    Miyauchi H; Horio T
    J Invest Dermatol; 1995 Mar; 104(3):364-9. PubMed ID: 7861003
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Tumor-promoting activity of 2,4-dinitrofluorobenzene.
    Maldve RE; Fischer SM
    Int J Cancer; 1995 Feb; 60(4):545-53. PubMed ID: 7829270
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Benzoyl peroxide: an integrated human safety assessment for carcinogenicity.
    Kraus AL; Munro IC; Orr JC; Binder RL; LeBoeuf RA; Williams GM
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):87-107. PubMed ID: 7784640
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of the carcinogenic potential of 2,4-dinitrofluorobenzene and its implications regarding mutagenicity testing.
    Warren ST; Doolittle DJ; Chang CC; Goodmann JI; Trosko JE
    Carcinogenesis; 1982; 3(2):139-45. PubMed ID: 7039854
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice.
    Argyris TS
    J Invest Dermatol; 1980 Oct; 75(4):360-2. PubMed ID: 6776204
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters.
    Goldstein BD; Witz G; Amoruso M; Stone DS; Troll W
    Cancer Lett; 1981 Jan; 11(3):257-62. PubMed ID: 6265062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.